Understanding the uptake of new hip replacement implants in the UK: a cohort study using data from the National Joint Registry for England and Wales

Objectives Primary: describe uptake of new implant components (femoral stem or acetabular cup/shell) for total hip replacements (THRs) in the National Joint Registry for England and Wales (NJR). Secondary: compare the characteristics of: (a) surgeons and (b) patients who used/received new rather tha...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrew Judge, Michael R Whitehouse, Ashley W Blom, Adrian Sayers, Chris M Penfold, J Mark Wilkinson, Linda Hunt
Format: Article
Language:English
Published: BMJ Publishing Group 2019-11-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/9/11/e029572.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846151399490977792
author Andrew Judge
Michael R Whitehouse
Ashley W Blom
Adrian Sayers
Chris M Penfold
J Mark Wilkinson
Linda Hunt
author_facet Andrew Judge
Michael R Whitehouse
Ashley W Blom
Adrian Sayers
Chris M Penfold
J Mark Wilkinson
Linda Hunt
author_sort Andrew Judge
collection DOAJ
description Objectives Primary: describe uptake of new implant components (femoral stem or acetabular cup/shell) for total hip replacements (THRs) in the National Joint Registry for England and Wales (NJR). Secondary: compare the characteristics of: (a) surgeons and (b) patients who used/received new rather than established components.Design Cohort of 618 393 primary THRs performed for osteoarthritis (±other indications) by 4979 surgeons between 2008 and 2017 in England and Wales from the NJR. We described the uptake of new (first recorded use >2008, used within 5 years) stems/cups, and variation in uptake by surgeons (primary objectives). We explored surgeon-level and patient-level factors associated with use/receipt of new components with logistic regression models (secondary objectives).Outcomes Primary outcomes: total number of new cups/stems, proportion of operations using new versus established components. Secondary outcomes: odds of: (a) a surgeon using a new cup/stem in a calendar-year, (b) a patient receiving a new rather than established cup/stem.Results Sixty-eight new cups and 72 new stems were used in 47 606 primary THRs (7.7%) by 2005 surgeons (40.3%) 2008–2017. Surgeons used a median of one new stem and cup (25%–75%=1–2 both, max=10 cups, max=8 stems). Surgeons performed a median total of 22 THRs (25%–75%=5–124, range=1–3938) in the period 2008–2017. Surgeons used new stems in a median of 5.0% (25%–75%=1.3%–16.1%) and new cups in a median of 9.4% (25%–75%=2.8%–26.7%) of their THRs. Patients aged <55 years old versus those 55–80 had higher odds of receiving a new rather than established stem (OR=1.83, 95% CI=1.73–1.93) and cup (OR=1.31, 95% CI=1.25–1.37). Women had lower odds of receiving a new stem (OR=0.87, 95% CI=0.84–0.90), higher odds of receiving a new cup (OR=1.06, 95% CI=1.03–1.09).Conclusions Large numbers of new THR components have been introduced in the NJR since 2008. 40% of surgeons have tried new components, with wide variation in how many types and frequency they have been used.
format Article
id doaj-art-76984d9c331b4e749d062755b93d20b7
institution Kabale University
issn 2044-6055
language English
publishDate 2019-11-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-76984d9c331b4e749d062755b93d20b72024-11-27T12:45:09ZengBMJ Publishing GroupBMJ Open2044-60552019-11-0191110.1136/bmjopen-2019-029572Understanding the uptake of new hip replacement implants in the UK: a cohort study using data from the National Joint Registry for England and WalesAndrew Judge0Michael R Whitehouse1Ashley W Blom2Adrian Sayers3Chris M Penfold4J Mark Wilkinson5Linda Hunt61 Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UKNational Institute for Health Research Bristol Biomedical Research Centre, University of Bristol, Bristol, UK2 National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UKMusculoskeletal Research Unit, Bristol Medical School, Southmead Hospital, University of Bristol, Bristol, UK1 Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK4 Metabolic Bone Unit, Sorby Wing, Northern General Hospital, Sheffield, UKMusculoskeletal Research Unit, Bristol Medical School, Bristol, UKObjectives Primary: describe uptake of new implant components (femoral stem or acetabular cup/shell) for total hip replacements (THRs) in the National Joint Registry for England and Wales (NJR). Secondary: compare the characteristics of: (a) surgeons and (b) patients who used/received new rather than established components.Design Cohort of 618 393 primary THRs performed for osteoarthritis (±other indications) by 4979 surgeons between 2008 and 2017 in England and Wales from the NJR. We described the uptake of new (first recorded use >2008, used within 5 years) stems/cups, and variation in uptake by surgeons (primary objectives). We explored surgeon-level and patient-level factors associated with use/receipt of new components with logistic regression models (secondary objectives).Outcomes Primary outcomes: total number of new cups/stems, proportion of operations using new versus established components. Secondary outcomes: odds of: (a) a surgeon using a new cup/stem in a calendar-year, (b) a patient receiving a new rather than established cup/stem.Results Sixty-eight new cups and 72 new stems were used in 47 606 primary THRs (7.7%) by 2005 surgeons (40.3%) 2008–2017. Surgeons used a median of one new stem and cup (25%–75%=1–2 both, max=10 cups, max=8 stems). Surgeons performed a median total of 22 THRs (25%–75%=5–124, range=1–3938) in the period 2008–2017. Surgeons used new stems in a median of 5.0% (25%–75%=1.3%–16.1%) and new cups in a median of 9.4% (25%–75%=2.8%–26.7%) of their THRs. Patients aged <55 years old versus those 55–80 had higher odds of receiving a new rather than established stem (OR=1.83, 95% CI=1.73–1.93) and cup (OR=1.31, 95% CI=1.25–1.37). Women had lower odds of receiving a new stem (OR=0.87, 95% CI=0.84–0.90), higher odds of receiving a new cup (OR=1.06, 95% CI=1.03–1.09).Conclusions Large numbers of new THR components have been introduced in the NJR since 2008. 40% of surgeons have tried new components, with wide variation in how many types and frequency they have been used.https://bmjopen.bmj.com/content/9/11/e029572.full
spellingShingle Andrew Judge
Michael R Whitehouse
Ashley W Blom
Adrian Sayers
Chris M Penfold
J Mark Wilkinson
Linda Hunt
Understanding the uptake of new hip replacement implants in the UK: a cohort study using data from the National Joint Registry for England and Wales
BMJ Open
title Understanding the uptake of new hip replacement implants in the UK: a cohort study using data from the National Joint Registry for England and Wales
title_full Understanding the uptake of new hip replacement implants in the UK: a cohort study using data from the National Joint Registry for England and Wales
title_fullStr Understanding the uptake of new hip replacement implants in the UK: a cohort study using data from the National Joint Registry for England and Wales
title_full_unstemmed Understanding the uptake of new hip replacement implants in the UK: a cohort study using data from the National Joint Registry for England and Wales
title_short Understanding the uptake of new hip replacement implants in the UK: a cohort study using data from the National Joint Registry for England and Wales
title_sort understanding the uptake of new hip replacement implants in the uk a cohort study using data from the national joint registry for england and wales
url https://bmjopen.bmj.com/content/9/11/e029572.full
work_keys_str_mv AT andrewjudge understandingtheuptakeofnewhipreplacementimplantsintheukacohortstudyusingdatafromthenationaljointregistryforenglandandwales
AT michaelrwhitehouse understandingtheuptakeofnewhipreplacementimplantsintheukacohortstudyusingdatafromthenationaljointregistryforenglandandwales
AT ashleywblom understandingtheuptakeofnewhipreplacementimplantsintheukacohortstudyusingdatafromthenationaljointregistryforenglandandwales
AT adriansayers understandingtheuptakeofnewhipreplacementimplantsintheukacohortstudyusingdatafromthenationaljointregistryforenglandandwales
AT chrismpenfold understandingtheuptakeofnewhipreplacementimplantsintheukacohortstudyusingdatafromthenationaljointregistryforenglandandwales
AT jmarkwilkinson understandingtheuptakeofnewhipreplacementimplantsintheukacohortstudyusingdatafromthenationaljointregistryforenglandandwales
AT lindahunt understandingtheuptakeofnewhipreplacementimplantsintheukacohortstudyusingdatafromthenationaljointregistryforenglandandwales